Augur S.A. c/ Sumampa S.A. (National Commercial Court of Appeals, date not stated in the consulted reporter)
The economic reasonableness of a capital increase and its relationship to the corporate interest and shareholders’ rights. The precedent is cited for the proposition that capital increases are not immune from judicial review when they depart from their financing function and become an instrument for harming minority shareholders.
«Augur S.A. c/ Sumampa S.A.»
What was at issue
The economic reasonableness of a capital increase and its relationship to the corporate interest and shareholders’ rights.
What was decided
The precedent is cited for the proposition that capital increases are not immune from judicial review when they depart from their financing function and become an instrument for harming minority shareholders.
- The precedent is cited for the proposition that capital increases are not immune from judicial review when they depart from their financing function and become an instrument for harming minority shareholders.
- The holding should be read in light of the legal interest protected in the area of capital increases, not solely by reference to the documentary form of the act.
- Evidence of the specific facts and of their impact on corporate or creditor rights is decisive when applying the precedent’s doctrine to another case.
Citation: CNCom., «Augur S.A. c/ Sumampa S.A.» — Jurisprudencia societaria y comercial
Practical application
It is commonly used together with Pereda and Block to analyze potentially abusive capital increases.
Frequently asked questions
What is the main takeaway from the case?
Does the rule apply automatically today?
What should be proven in similar litigation?
Do you need advice on this matter?
The firm is headquartered in Buenos Aires, Argentina, and advises clients worldwide.
Contact the firm